Cargando…

Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival

INTRODUCTION: Presence of disseminated tumor cells (DTCs) in bone marrow (BM) and circulating tumor cells (CTC) in peripheral blood (PB) predicts reduced survival in early breast cancer. The aim of this study was to determine the presence of and alterations in DTC- and CTC-status in locally advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathiesen, Randi R, Borgen, Elin, Renolen, Anne, Løkkevik, Erik, Nesland, Jahn M, Anker, Gun, Østenstad, Bjørn, Lundgren, Steinar, Risberg, Terje, Mjaaland, Ingvil, Kvalheim, Gunnar, Lønning, Per Eystein, Naume, Bjørn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680942/ https://www.ncbi.nlm.nih.gov/pubmed/22889108 http://dx.doi.org/10.1186/bcr3242

Ejemplares similares

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
por: Knappskog, Stian, et al.
Publicado: (2012)

CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer
por: Chrisanthar, Ranjan, et al.
Publicado: (2008)

Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel
por: Chrisanthar, Ranjan, et al.
Publicado: (2011)

Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
por: Synnestvedt, Marit, et al.
Publicado: (2012)

NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients
por: Borgen, Elin, et al.
Publicado: (2018)

Concomitant inactivation of the p53‐ and pRB‐ functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo
por: Knappskog, Stian, et al.
Publicado: (2015)

The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients
por: Mikalsen, Lars Tore Gyland, et al.
Publicado: (2013)

Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
por: Helland, Thomas, et al.
Publicado: (2020)

Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients
por: Gilje, Bjørnar, et al.
Publicado: (2014)

Next-Generation Sequencing of Disseminated Tumor Cells
por: Møller, Elen K., et al.
Publicado: (2013)

Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases
por: Seeberg, Lars Thomas, et al.
Publicado: (2017)

Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information
por: Hugenschmidt, Harald, et al.
Publicado: (2020)

Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial
por: Engebraaten, Olav, et al.
Publicado: (2012)

Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing
por: Demeulemeester, Jonas, et al.
Publicado: (2016)

Monitoring of minimal residual cancer in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
por: Drageset, V, et al.
Publicado: (2005)

Evaluation of MetriGenix custom 4D™ arrays applied for detection of breast cancer subtypes
por: Muggerud, Aslaug Aamodt, et al.
Publicado: (2006)

Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties
por: Ma, Yuanyuan, et al.
Publicado: (2011)

Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer
por: Wist, E. A., et al.
Publicado: (2012)

Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
por: Ma, Yuanyuan, et al.
Publicado: (2012)

Preoperative CTC-Detection by CellSearch(®) Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
por: Hugenschmidt, Harald, et al.
Publicado: (2021)

Regional radiotherapy after primary systemic treatment for cN+ breast cancer patients
por: Boersma, Liesbeth J., et al.
Publicado: (2023)

MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
por: Li, Xiaoran, et al.
Publicado: (2016)

Correction: MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
por: Li, Xiaoran, et al.
Publicado: (2017)

Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016
por: Nilssen, Yngvar, et al.
Publicado: (2020)

Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
por: Krüger, Kristi, et al.
Publicado: (2021)

Strength and weakness of phase I to IV trials, with an emphasis on translational aspects
por: Lønning, Per Eystein
Publicado: (2008)

Are current development programs realising the full potential of new agents?
por: Lønning, Per Eystein
Publicado: (2010)

Tailored targeted therapy for all: a realistic and worthwhile objective?
por: Lønning, Per Eystein
Publicado: (2009)

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
por: Helland, Thomas, et al.
Publicado: (2017)

Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
por: Schaner, Marci E, et al.
Publicado: (2005)

Disseminated tumour cells as a prognostic biomarker in colorectal cancer
por: Flatmark, K, et al.
Publicado: (2011)

The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
por: Molloy, Timothy J, et al.
Publicado: (2011)

Rettigheter og tvang i kommunale hjelpetilbud til personer med alvorlige samtidige rus- og psykiske lidelser: erfaringer med regelverket, i lys av menneskerettigheter
por: Bendixen, Ane, et al.
Publicado: (2023)

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2015)

BRCA1 methylation in newborns: genetic disposition, maternal transfer, environmental influence, or by chance only?
por: Lønning, Per Eystein, et al.
Publicado: (2018)

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
por: Silwal-Pandit, Laxmi, et al.
Publicado: (2015)

Inverse Regulation of EGFR/HER1 and HER2-4 in Normal and Malignant Human Breast Tissue
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2013)

Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016
por: Nilssen, Yngvar, et al.
Publicado: (2022)

Session 6 introduction
por: Robertson, John FR, et al.
Publicado: (2010)

Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved
por: Lønning, Per Eystein, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1gvq55bnme5lsm9n8d3s1vuhgp